Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients

Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients

Matin M¹ ; Asilian A¹ ; Mozafarpoor S¹ ; Haftbaradaran E²

Show Affiliations

1. Skin Diseases and Leishmaniasis Research Center and Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2. Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2016

Abstract

Background: Cutaneous benign lymphoid hyperplasia (CLH) is a B-cell pseudolymphoma of unknown origin and the most involving site is the face. Case Report: This report presents 4 CLH patients treated with rituximab. Conclusion: Rituximab may be useful for resistant or relapsing forms of CLH who failed other forms of therapy. © 2016. Isfahan University of Medical Sciences(IUMS). All rights reserved.

Style	Citing Format
MLA	Matin M, et al.. "Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients." Journal of Isfahan Medical School, vol. 34, no. 371, 2016, pp. -.
APA	Matin M, Asilian A, Mozafarpoor S, Haftbaradaran E (2016). Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients. Journal of Isfahan Medical School, 34(371), -.
Chicago	Matin M, Asilian A, Mozafarpoor S, Haftbaradaran E. "Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients." Journal of Isfahan Medical School 34, no. 371 (2016): -.
Harvard	Matin M et al. (2016) 'Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients', Journal of Isfahan Medical School, 34(371), pp. -.
Vancouver	Matin M, Asilian A, Mozafarpoor S, Haftbaradaran E. Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients. Journal of Isfahan Medical School. 2016;34(371):-.
BibTex	@article{ author = {Matin M and Asilian A and Mozafarpoor S and Haftbaradaran E}, title = {Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients}, journal = {Journal of Isfahan Medical School}, volume = {34}, number = {371}, pages = {-}, year = {2016} }
RIS	TY - JOUR AU - Matin M AU - Asilian A AU - Mozafarpoor S AU - Haftbaradaran E TI - Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients JO - Journal of Isfahan Medical School VL - 34 IS - 371 SP - EP - PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract